000			01939 a2200541 4500
005			20250516180248.0
264		0	_c20140616
008			201406s 0 0 eng d
022			_a2047-9980
024	7		_a10.1161/JAHA.113.000355 _2doi
040			_aNLM _beng _cNLM
100	1		_aMcCommis, Kyle S
245	0	0	_aCardiac-specific hexokinase 2 overexpression attenuates hypertrophy by increasing pentose phosphate pathway flux. _h[electronic resource]
260			_bJournal of the American Heart Association _cNov 2013
300			_ae000355 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAdrenergic alpha-Agonists _xpharmacology
650	0	4	_aAnimals
650	0	4	_aAnimals, Newborn
650	0	4	_aCardiomegaly _xchemically induced
650	0	4	_aCell Death
650	0	4	_aCells, Cultured
650	0	4	_aDehydroepiandrosterone _xpharmacology
650	0	4	_aDisease Models, Animal
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aFemale
650	0	4	_aGlucosephosphate Dehydrogenase _xantagonists & inhibitors
650	0	4	_aHexokinase _xgenetics
650	0	4	_aIsoproterenol
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Transgenic
650	0	4	_aMyocytes, Cardiac _xdrug effects
650	0	4	_aOxidative Stress
650	0	4	_aPentose Phosphate Pathway _xdrug effects
650	0	4	_aPhenylephrine _xpharmacology
650	0	4	_aRNA Interference
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aReactive Oxygen Species _xmetabolism
650	0	4	_aTime Factors
650	0	4	_aTransfection
700	1		_aDouglas, Diana L
700	1		_aKrenz, Maike
700	1		_aBaines, Christopher P
773	0		_tJournal of the American Heart Association _gvol. 2 _gno. 6 _gp. e000355
856	4	0	_uhttps://doi.org/10.1161/JAHA.113.000355 _zAvailable from publisher's website
999			_c23230317 _d23230317